AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 05 2021
News
Covid: Pfizer says antiviral pill 89% effective in high risk cases
An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug - Paxlovid - is intended for use soon after symptoms develop in people at high risk of severe disease.
It comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp
BBC News
Nov 24 2021
News
US hospitals prepare for influx of Covid patients as millions travel for Thanksgiving
As cases begin surging once more in the US, millions of people are expected to travel for the Thanksgiving holiday, and health workers and hospital systems are now preparing for an influx of Covid patients after having little time to recover from the summer surge.
Last year, there was a major surge in cases around the holidays. But this year, new tools could blunt the spread – if they
The Guardian
Aug 18 2020
Data
What Is It Like to Work With Androids?
Last summer, the €16 billion science and technology company Merck KGaA, Darmstadt, Germany, brought in an HR specialist named Elenoide to handle employee development questions at HQ.
Brought, not hired. Elenoide is an android, a carefully crafted work of robotics capable of some of the most advanced AI known to HR tech.
Elenoide isn't meant to replace or even supplement the
Gallup
Mar 02 2021
News
Biden says U.S. will have enough vaccines for 300 million adults by end of May
President Biden on Tuesday said that ramped-up coronavirus vaccine production will provide enough doses for 300 million Americans by the end May.
Why it matters: That's two months sooner than Biden's previous promise of enough vaccines for all American adults by the end of July.
The accelerated timeline also comes on the heels of pharmaceutical manufacturer Merck teaming up with
Axios
Mar 02 2021
News
Biden: US will have enough COVID vaccines for every adult by the ‘end of May’
President Biden on Tuesday said that the US will now have enough COVID-19 vaccines for every adult “by the end of May” — and that the feds will start a new program aimed at vaccinating all teachers by the end of March.
The ambitious timeline — less than three months away — comes days after US health regulators approved a third vaccine, developed by Johnson & Johnson, which requires
New York Post (News)
Mar 04 2021
Opinion
Is the press too pessimistic about the pandemic?
YESTERDAY, PRESIDENT BIDEN gave a speech at the White House and said that the US is on track to have enough vaccine supply to cover every adult in America by the end of May—a two-month improvement on his administration’s previous timeline. Biden announced that the federal government has taken steps to accelerate the production of Johnson & Johnson’s vaccine, including helping to finalize a
Columbia Journalism Review
Mar 02 2021
News
Biden promises vaccine supply for all US adults by end of May
The United States will have enough coronavirus vaccine doses for every adult in the country by the end of May, President Joe Biden announced on Tuesday, as production of a third vaccine is set to ramp up.
During a news conference at the White House, Biden said he had invoked a wartime production law to require pharmaceutical company Merck & Co to help produce a newly approved
Al Jazeera
Apr 15 2021
Analysis
Corporate America’s Empty Virtue Signaling
Critics of the Georgia elections law have gotten far out over their skis. The Washington Post fact-checker awarded Joe Biden “Four Pinocchios” for lying about the bill, then labeled him a “recidivist” when he kept repeating the lie. Senator Raphael Warnock admitted to Fox News that he had put his name to an email for a liberal nonprofit lying about a provision that was not in the final bill.
National Review
Oct 13 2020
Opinion
Vaccine development process is safe, claims of the contrary are baseless
All of our lives have been drastically impacted by the ongoing coronavirus pandemic — and we know all of us are eager to return to the way things were before the pandemic began. However, that simply won’t be possible without a safe, effective vaccine. Fortunately, due to the strength of American innovation and unprecedented public-private partnerships, a COVID-19 vaccine is on the horizon. We
Multiple Writers - Lean Right
May 26 2020
News
Stocks soar as New York Stock Exchange reopens floor to traders
Stock roared Tuesday coming off the holiday weekend, as the national shutdown continues to unwind, more drug companies chase coronavirus vaccines and the New York Stock Exchange reopened its floor to traders for the first time in two months.
The Dow Jones industrial average shot up nearly 600 points, about 2.3 percent, to push the blue-chip index past the 25,000 threshold. The Standard
Washington Post